Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Frans H. O'Neill"'
Publikováno v:
The American Journal of Cardiology. 96:29-36
Published data suggest that the cholesterol-lowering effect of dietary plant sterol esters is less marked in longer-term than in short-term studies, whereas plant stanol esters maintain their efficacy. To investigate this further, healthy subjects an
Publikováno v:
Clinical Chemistry. 51:904-907
Dysbetalipoproteinemia (type III hyperlipidemia) is a highly atherogenic mixed hyperlipidemia characterized by the accumulation of remnants of triglyceride-rich lipoproteins (chylomicrons and VLDL) (1). The binding of these remnants to hepatic lipopr
Publikováno v:
International Journal of Obesity. 27:862-865
OBJECTIVE: We aimed to study the effect of atorvastatin, a statin, on cholesterol synthesis and absorption and VLDL-apoB metabolism in obese men with the metabolic syndrome. METHODS: A total of 25 dyslipidaemic obese men were randomized to atorvastat
Autor:
Trevor G. Redgrave, Gerald F. Watts, P. Hugh R. Barrett, Dick C. Chan, Gilbert R. Thompson, Frans H. O’Neill
Publikováno v:
Clinical Science. 104:383-388
The dysmetabolic syndrome of insulin resistance and visceral obesity is characterized by elevated plasma concentration of triacylglycerol-rich lipoprotein (TRL) remnants that may be related to increased cardiovascular risk. Perturbed hepato-intestina
Autor:
Anne K. Soutar, Rossitza P. Naoumova, Gilbert R. Thompson, Graham W. Taylor, Frans H. O’Neill, Dilip D. Patel, Brian L. Knight, Mafalda Bourbon, Clare Neuwirth
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 21:832-837
Abstract —Interindividual variability in low density lipoprotein (LDL) cholesterol (LDL-C) response during treatment with statins is well documented but poorly understood. To investigate potential metabolic and genetic determinants of statin respon
Publikováno v:
Obesity research. 11(4)
CHAN, DICK C., GERALD F. WATTS, P. HUGH R. BARRETT, FRANS H. O’NEILL, AND GILBERT R. THOMPSON. Plasma markers of cholesterol homeostasis and apolipoprotein B-100 kinetics in the metabolic syndrome. Obes Res. 2003;11:591-596. Objective: The metaboli
Publikováno v:
European heart journal. 23(3)
The advent of the statins, competitive inhibitors of HMG CoA reductase and thus of cholesterol synthesis, has revolutionized the treatment and prevention of coronary heart disease. The reduction in coronary heart disease events in dyslipidaemic subje
Publikováno v:
Atherosclerosis Supplements. 2:110